<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01627756</url>
  </required_header>
  <id_info>
    <org_study_id>2894-2008</org_study_id>
    <nct_id>NCT01627756</nct_id>
  </id_info>
  <brief_title>Continued Ventilation During Cardiopulmonary Bypass</brief_title>
  <official_title>Continued Mechanical Ventilation During CABG Operation Attenuates Systemic Immune Modulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cardiopulmonary bypass (CPB) is well known to induce a strong anti-inflammatory response. The
      investigators examined whether continued mechanical ventilation during CPB alters systemic
      immune activation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiopulmonary bypass is well known to induce a strong anti-inflammatory response. Studies
      had been shown that the contact of blood components with artificial surfaces, the surgical
      trauma, endotoxemia and a reperfusion injury are in part responsible for the seen
      immunological affect after surgery. The purpose of this study is to test the effect of
      continued mechanical ventilation during surgery on a blood marker called soluble ST2 in
      patients sera. Soluble ST2 acts as a decoy receptor of IL-33 and has anti-inflammatory
      effects. Elevated soluble ST2 concentrations are reported in patients with acute myocardial
      infarction, sepsis, congestive heart failure and elevates soluble ST2 levels are associated
      with adverse outcome.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">August 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alteration of soluble ST2 concentration in serum</measure>
    <time_frame>Preoperative, postoperative, day 1, day 2, day 3, day 4, day 5 after surgery</time_frame>
    <description>Concentration of soluble ST2 will be assessed in the serum of patient´s preoperativem, postoperative and the following five consecutive days after surgery.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Ventilation Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Volume controlled ventilation was done during the whole surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-ventilation Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>In the non-ventilated group lungs were collapsed after completion of CPB until after weaning from the extracorporeal circulation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Lung Ventilation</intervention_name>
    <description>In the ventilated group, mechanical ventilation was done with the half of the initial tidal volume (i.e. 3-4 ml/kg, 250-300ml) during the aortic cross-clamp.</description>
    <arm_group_label>Ventilation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non-ventilated Group</intervention_name>
    <description>. In the non-ventilated group lungs were collapsed after completion of CPB until after weaning from the extracorporeal circulation.</description>
    <arm_group_label>Non-ventilation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  age &gt; 40 and &lt; 80

        Exclusion Criteria:

          -  treatment with steroids or immunomodulatory interventions during the past four weeks

          -  signs of an acute infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hendrik Jan Ankersmit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University of Debrecen</name>
      <address>
        <city>Debrecen</city>
        <zip>Nagyerdei krt. 98</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Szerafin T, Niederpold T, Mangold A, Hoetzenecker K, Hacker S, Roth G, Lichtenauer M, Dworschak M, Wolner E, Ankersmit HJ. Secretion of soluble ST2 - possible explanation for systemic immunosuppression after heart surgery. Thorac Cardiovasc Surg. 2009 Feb;57(1):25-9. doi: 10.1055/s-2008-1039044. Epub 2009 Jan 23.</citation>
    <PMID>19169993</PMID>
  </reference>
  <reference>
    <citation>Szerafin T, Hoetzenecker K, Hacker S, Horvath A, Pollreisz A, Arpád P, Mangold A, Wliszczak T, Dworschak M, Seitelberger R, Wolner E, Ankersmit HJ. Heat shock proteins 27, 60, 70, 90alpha, and 20S proteasome in on-pump versus off-pump coronary artery bypass graft patients. Ann Thorac Surg. 2008 Jan;85(1):80-7.</citation>
    <PMID>18154785</PMID>
  </reference>
  <reference>
    <citation>Szerafin T, Horvath A, Moser B, Hacker S, Hoetzenecker K, Steinlechner B, Brunner M, Roth G, Boltz-Nitulescu G, Peterffy A, Wolner E, Ankersmit HJ. Apoptosis-specific activation markers in on- versus off-pump coronary artery bypass graft (CABG) patients. Clin Lab. 2006;52(5-6):255-61.</citation>
    <PMID>16812952</PMID>
  </reference>
  <reference>
    <citation>Szerafin T, Brunner M, Horváth A, Szentgyörgyi L, Moser B, Boltz-Nitulescu G, Péterffy A, Hoetzenecker K, Steinlechner B, Wolner E, Ankersmit HJ. Soluble ST2 protein in cardiac surgery: a possible negative feedback loop to prevent uncontrolled inflammatory reactions. Clin Lab. 2005;51(11-12):657-63.</citation>
    <PMID>16329625</PMID>
  </reference>
  <reference>
    <citation>Mildner M, Storka A, Lichtenauer M, Mlitz V, Ghannadan M, Hoetzenecker K, Nickl S, Dome B, Tschachler E, Ankersmit HJ. Primary sources and immunological prerequisites for sST2 secretion in humans. Cardiovasc Res. 2010 Sep 1;87(4):769-77. doi: 10.1093/cvr/cvq104. Epub 2010 Apr 2.</citation>
    <PMID>20363761</PMID>
  </reference>
  <reference>
    <citation>Ng CS, Arifi AA, Wan S, Ho AM, Wan IY, Wong EM, Yim AP. Ventilation during cardiopulmonary bypass: impact on cytokine response and cardiopulmonary function. Ann Thorac Surg. 2008 Jan;85(1):154-62.</citation>
    <PMID>18154801</PMID>
  </reference>
  <verification_date>June 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 19, 2012</study_first_submitted>
  <study_first_submitted_qc>June 25, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2012</study_first_posted>
  <last_update_submitted>June 25, 2012</last_update_submitted>
  <last_update_submitted_qc>June 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Hendrik Jan Ankersmit</investigator_full_name>
    <investigator_title>Assoc. Prof</investigator_title>
  </responsible_party>
  <keyword>Thoracic Surgery</keyword>
  <keyword>Endotoxins</keyword>
  <keyword>Respiration, Artificial</keyword>
  <keyword>Immune System</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

